---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-122288"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:30:49.699940+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sera Prognostics Q3 revenue $29k, net loss $7.9M; PRIME study data locked

## Summary
- Revenue fell to $29k from $42k YoY; net loss widened to $7.9M from $7.2M.
- Operating expenses $8.9M, up 8% YoY; SG&A $5.4M due to growth investments.
- PRIME study database locked in Sept; results planned for 2025 conferences and journal submission.
- Direct-to-consumer PreTRM testing via website launched Oct 1; TV awareness campaign with Dennis Quaid and Meg Ryan.
- Ambient whole blood collection lowers cost of goods and boosts lab capacity for scalability.

## SEC filing metadata
- accession: 0000950170-24-122288
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000095017024122288/0000950170-24-122288-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000095017024122288/sera-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-122288
- JSON: https://secwatch.observer/filing/0000950170-24-122288.json
- Plain text: https://secwatch.observer/filing/0000950170-24-122288.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.